Supplementary scales for the school-age forms of the Achenbach System of Empirically Based Assessment rated by adolescents, parents, and teachers: Psychometric properties in German samples

Plück, Julia; Nawab, Laurence; Kamenetzka, Elena; Döpfner, Manfred

doi:10.2478/sjcapp-2025-0004

Figures & Tables

Scale scores and internal consistencies in clinic and community sample across informants

	CBCL/6–18									YSR/11–18									TRF/6–18
Origin		Clinic				Community					Clinic				Community					Clinic
N		1288				2471					755				1797					836
Age (years)
M		11.5					12.3				14.0					13.9				10.9
(SD)		(3.3)					(3.3)				(2.1)					(2.2)				(3.1)
Male%		64.7					50.5				56.4					51.4				69.9

Scale	(n_it)	Ω	r_it(Range)	M	SD	Ω	r_it(Range)	M	SD	(n_it)	Ω	r_it(Range)	M	SD	Ω	r_it(Range)	M	SD	(n_it)	Ω	r_it(Range)	M	SD
SPS	(14)	.72	(.18-.50)	9.07	4.56	.74	(.29-.44)	2.86	2.90	(14)	.79	(.23-.61)	8.89	5.02	.78	(.26-50)	4.57	3.81	(13)	.69	(.21-.53)	5.98	4.14
OCP	(8)	.69	(.26-.51)	3.18	2.86	.54	(.19-.37)	0.80	1.27	(8)	.74	(.33-.55)	3.92	3.37	.64	(.23-.44)	1.56	1.96	(8)	.66	(.26-.45)	1.82	2.36
SCT^1,2	(4)	.66	(.34-.54)	1.79	1.77	.50	(.27-.33)	0.51	0.91										(5)	.81	(.47-.66)	2.73	2.65
PQS³										(14)	.73	(.14-.47)	18.83	4.37	.87	(.29-.68)	17.09	6.19
DRS1	(41)	.89	(.14-.60)	24.32	12.22	.89	(.19-.53)	8.31	7.57	(39)	.89	(.20-.63)	21.33	11.34	.91	(.22-.58)	12.71	9.51	(62)	.95^A	(-.02-.71)	30.79	20.59
DRS2	(41)	.89	(.14-.60)	24.30	11.98	.89	(.19-.53)	8.23	7.54	(39)	.89	(.20-.63)	22.11	11.61	.91	(.22-.58)	12.93	9.71	(62)	.95^A	(-.02-.71)	29.08	19.52
ASD1	(9)	.58	(.13-.43)	3.56	2.81	.52	(.15-.33)	0.98	1.42	(9)	.51	(.12-.31)	3.57	2.70	.56	(.22-.33)	1.65	1.89	(9)	.63	(.15-.48)	2.77	2.67
ASD2	(10)	.64	(.20-.43)	3.99	3.13	.60	(.20-.37)	1.08	1.59	(9)	.58	(.22-.39)	3.97	2.88	.60	(.23-.37)	1.82	1.99	(10)	.74	(.29-.53)	3.74	3.48
ASD3¹	(15)	.78	(.21-.55)	6.76	4.87	.76	(.19-.46)	1.97	2.63	(14)	.72	(.18-.45)	6.69	4.37	.75	(.22-.45)	3.40	3.30	(15)	.80	(.22-.59)	6.02	4.95
MAS¹	(19)	.79	(.13-.59)	8.26	5.25	.76	(.13-.49)	2.73	3.04	(17)	.75	(.19-.46)	7.94	4.78	.81	(.21-.49)	4.93	4.13	(15)	.87	(.03-.73)	6.07	5.35

Mean differences between clinic and community samples for the CBCL/6–18 and YSR/11–18_

	CBCL/6–18							YSR/11–18
Origin N	Clinic 1288		Community 2471					Clinic 755		Community 1797 (n_PQS = 1791)

Scale	M	SD	M	SD	t	df	d	M	SD	M	SD	t^L	df	d
SPS	9.07	4.56	2.86	2.90	44.42	1843.22	1.75	8.89	5.02	4.57	3.81	21.24	1135.13	1.03
OCP	3.18	2.86	0.80	1.27	28.43	1558.42	1.21	3.92	3.37	1.56	1.96	17.96	974.37	0.96
SCT¹	1.79	1.77	0.51	0.91	24.25	1649.10	1.00
PQS²								18.83	4.37	17.09	6.19	8.02	1974.84	0.30
DRS1	24.32	12.22	8.32	7.57	42.92	1816.33	1.70	21.33	11.34	12.71	9.51	18.35	1220.90	0.85
DRS2	24.30	11.98	8.23	7.54	43.80	1831.65	1.73	22.11	11.62	12.93	9.71	19.09	1217.43	0.89
ASD1	3.56	2.81	0.98	1.42	30.99	1640.01	1.29	3.57	2.70	1.65	1.89	17.77	1077.19	0.89
ASD2	3.99	3.13	1.08	1.59	31.34	1638.54	1.30	3.97	2.88	1.82	1.99	18.74	1069.62	0.94
ASD3	6.76	4.87	1.97	2.63	32.84	1686.72	1.34	6.69	4.37	3.40	3.30	18.59	1131.57	0.90
MAS	8.26	5.25	2.73	3.04	34.83	1748.99	1.40	7.94	4.78	4.93	4.13	15.09	1249.71	0.69

Mean differences of supplementary scales between clinic subgroups with and without the nearest respective diagnosis1

		CBCL/6–18							YSR/11–18							TRF/6–18

Scale	Group	n	M	SD	t	df	p	d	n	M	SD	t	df	p	d	n	M	SD	t	df	p	d
OCP	Y	74	6.85	3.37	-	78.70	<.001	1.44	62	6.95	3.62	-	753	<.001	1.02	32	3.25	2.27	-3.52	834	<.001	0.64
	N	1214	2.96	2.67	9.77^w				693	3.65	3.22	7.67				804	1.76	2.34
ASD1	Y	68	6.96	3.48	-	71.36	<.001	1.33	29	5.14	3.17	-	753	.001	0.61	53	5.57	3.01	-8.16	834	<.001	1.16
	N	1220	3.37	2.64	8.37^w				726	3.50	2.66	3.22				783	2.58	2.54
ASD2	Y	68	7.79	3.60	-	1286	<.001	1.34	29	5.10	3.31	-	753	.030	0.41	53	7.43	4.05	-	56.74	<.001	1.18
	N	1220	3.78	2.96	10.74				726	3.92	2.85	2.17				783	3.49	3.29	6.93^w
ASD3	Y	68	12.24	4.96	-9.87	1286	<.001	1.23	29	8.59	4.62	-	753	.017	0.45	53	10.25	5.58	-6.60	834	<.001	0.94
	N	1220	6.45	4.69					726	6.61	4.34	2.39				783	5.73	4.77

Pearson Correlations of supplement scales with age and gender within both samples for each informant

		CBCL/6–18R				YSR/11–18R				TRF/6–18R
Origin		Clinic		Community		Clinic		Community		Clinic
N		1288		2471		755		1797		836
n_female		455		1224		326		874		251
n_male		833		1247		429		923		585

Scale		r	CI_r	r	CI_r	r	CI_r	r	CI_r	r	CI_r
SPS	Age	.06	[.00, .11]	-.01	[-.05, .03]	.21*	[.14, .28]	.06	[.01, .10]	.07	[<.01, .14]
SPS	Gender¹	.06	[<.01, .12]	.01	[-.03, .05]	.29*	[.22, .35]	.08*	[.04, .13]	-.08	[-.15, -.02]
OCP	Age	.11*	[.05, .16]	.05	[<.01, .09]	.27*	[.20, .33]	.11*	[.06, .15]	.06	[<-.01, .13]
OCP	Gender	.12*	[.07, .18]	.01	[-.03, .05]	.32*	[.26, .38]	.07*	[.02, .11]	.02	[-.05, .08]
SCT²	Age	.09*		<-.01	[-.06, .05]	-		-		.08	[.01, .14]
SCT²	Gender	<.01	[-.05, .06]	-.02	[-.06, .02]	-		-		-.09*	[-.16, -.02]
PQS³	Age	-		-		-.10*	[-.17, -.03]	.12*	[.08, .17]	-
PQS³	Gender	-		-		-.04	[-.11, .03]	.07*	[.03, .12]	-
DRS1	Age	-.10*	[-.15, -.05]	-.04	[-.08, <-.01]	.16*	[.09, .23]	.06	[.01, .10]	-.11*	[-.17, -.04]
DRS1	Gender	-.15*	[-.20, -.09]	-.07*	[-.11. -.03]	.18*	[.11, .24]	.04	[-.01, .08]	-.27*	[-.33, -.20]
DRS2	Age	-.09*	[-.14, -.03]	-.04	[-.08, <.01]	.15*	[.08, .22]	.04	[<-.01, .09]	-.09*	[-.16, -.02]
DRS2	Gender	-.15*	[-.20, -.10]	-.07*	[-.11, -.03]	.18*	[.11, .24]	.04	[-.01, .08]	-.24*	[-.31, -.18]
ASD1	Age	.04	[-.01, .10]	-.02	[-.06, .02]	.18*	[.11, .25]	.02	[-.02, .07]	-.01	[-.08, .06]
ASD1	Gender	-.06	[-.12, -.01]	-.01	[-.05, .03]	.15*	[.08, .22]	.06	[<.01, .10]	-.14*	[-.21, -.07]
ASD2	Age	.07*	[.02, .13]	.01	[-.03, .05]	.24*	[.18, .31]	.08*	[.03, .12]	.01	[-.05, .08]
ASD2	Gender	-.03	[-.08, .03]	-.03	[-.07, .01]	.18*	[.11, .25]	.07*	[.02, .11]	-.11*	[-.18, -.04]
ASD3	Age	.08*	[.03, .13]	-.01	[-.05, .03]	.27*	[.20, .34]	.07*	[.02, .11]	.04	[-.03, .11]
ASD3	Gender	.01	[-.05, .07]	<.01	[-.04, .04]	.20*	[.13, .27]	.07*	[.03, .12]	.08	[-.15, -.01]
MAS	Age	-.20*	[-.25, -.14]	-.07*	[-.11, .03]	.07	[< -.01, .14]	.06*	[.02, .11]	-.15*	[-.21, -.08]
MAS	Gender	-.25*	[-.30, -.19]	-.10*	[-.14, -.06]	.07	[<.01, .14]	-.02	[-.07, .02]	-.28*	[-.34, -.22]

Cross-informant Pearson correlations in community and clinic sample_

	Community		Clinic
N	CBCLxYSR		CBCLxYSR		CBCLxTRF		TRFxYSR
N	1757			705		799		396

Scale	r	CI_r	r	CI_r	r	CI_r	r	CI_r
SPS	.50	[.47,.54]	.35	[.28,.41]	.20	[.13,.27]	.09⁺	[-.01,.18]
OCP	.35	[.31,.39]	.41	[.35,.47]	.20	[.14,.27]	.21	[.12,.30]
SCT¹	-		.33	[.26,.39]	-		-
DRS1	.53	[.50,.57]	.34	[.27,.40]	.35	[.29,.41]	.15	[.05,.24]
DRS2	.53	[.48,.56]	.33	[.26,.39]	.33	[.27,.39]	.14	[.04,.23]
ASD1	.39	[.35,.43]	.33	[.26,.40]	.35	[.28,.41]	.19	[.10,.29]
ASD2	.38	[.34,.42]	.30	[.24,.37]	.35	[.29,.41]	.13	[.04,.23]
ASD3	.44	[.41,.48]	.34	[.27,.41]	.38	[.32,.44]	.19	[.09,.28]
MAS	.46	[.42,.50]	.36	[.29,.42]	.40	[.34,.46]	.25	[.15,.34]

Supplementary scales for the school-age forms of the Achenbach System of Empirically Based Assessment rated by adolescents, parents, and teachers: Psychometric properties in German samples

Figures & Tables

Scale scores and internal consistencies in clinic and community sample across informants

Mean differences between clinic and community samples for the CBCL/6–18 and YSR/11–18_

Mean differences of supplementary scales between clinic subgroups with and without the nearest respective diagnosis1

Pearson Correlations of supplement scales with age and gender within both samples for each informant

Cross-informant Pearson correlations in community and clinic sample_

Paradigm

My account